Global Health, HIV, & AIDS: A New Consensus?
Sixteen years after the advent of protease inhibitors and effective combination therapy for HIV infection, the nature of the AIDS epidemic is changing. While some milestones for global efforts to halt the epidemic have been missed, notably Millenium Development Goal 6.2 (‘achieve universal access to treatment for all those who need it by 2010’), optimism is brewing that an effective and powerful synthesis of biomedical and behavioral, or clinical and community, approaches will yield substantial gains against the disease (UNAIDS 2011). Therapeutic suppression of virus in persons and in populations reduces new infections while also enabling survival and improving the quality of life for those already infected. Nevertheless, any realization of the promise of anti-retroviral therapy requires sustained social/scientific effort: anti-retroviral therapy opens up new challenges and problems in both biomedical and sociopolitical terms.
Areas of Research Interest
- What are the biological, clinical, epidemiological, and health-systems implications of long-term ART? Researchers: Professor Sam McConkey, Dr. Fiona O’Brien, Dr. Thomas Strong, Dr. Jamie Saris
- Critical analysis of (bio)political economies of anti-retroviral therapy Researchers: Dr. Fiona O’Brien, Dr. Jamie Saris, Dr. Thomas Strong)
- Research on the cultural politics of AIDS. Researchers: Dr. Becca Cassidy, Dr. Thomas Strong, Professor Gerry Kearns, Professor Sam McConkey